NPBiosciences is a cutting edge biotech company dedicated to developing revolutionary platforms based on humanized mice to accelerate discovery and development of novel therapies. The ground-breaking science was generated from three distinguished laboratories at the Massachusetts Institute of Technology (MIT), the University of North Carolina (UNC) and Singapore-MIT Alliance for Research and Technology (SMART).
The technology development and utilization at NPBiosciences are protected through exclusive licenses of the relevant intellectual properties from MIT, SMART, and UNC.
NPBiosciences has operations based in Singapore, US and China.